Light Mode
$102.10 ↑ +0.00 (+0.00%) Trading Up from the previous close of $102.10, $0.15 below the day’s high of $102.25
+9.21 (+9.91%) / 6M
Momentum, market sentiment, and recent alerts
LNTH reads very good: price sits above both the 20- and 200-day averages, the 12-month move is +93.4%.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
Lantheus Holdings, Inc. engages in the provision of diagnostic imaging and nuclear medicine products. The firm develops products that help healthcare professionals in patient management and outcomes and assists clinicians with the detection of cardiovascular disease. It operates through the following geographical segments U.S. and International. The U.S. segment produces and markets products, radiopharmacies, PMFs, integrated delivery networks, hospitals, clinics, and group practices throughout the United States. The International segment offers direct distribution in Canada and third-party distribution relationships in Europe, Canada, Australia, Asia-Pacific, Central America, and South America. The company was founded in 1956 and is headquartered in Bedford, MA.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.